Karyopharm Therapeutics Inc.
KPTI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $62,476 | $52,231 | $135,188 | $190,459 |
| Short-Term Investments | $46,236 | $139,212 | $142,779 | $38,156 |
| Receivables | $30,766 | $26,962 | $47,086 | $22,497 |
| Inventory | $4,739 | $3,043 | $4,224 | $4,106 |
| Other Curr. Assets | $12,275 | $12,473 | $20,885 | $20,388 |
| Total Curr. Assets | $156,492 | $233,921 | $350,162 | $275,606 |
| Property Plant & Equip (Net) | $6,284 | $4,882 | $7,377 | $9,557 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1,642 | $1,635 | $633 | $20,142 |
| Total NC Assets | $7,926 | $6,517 | $8,010 | $29,699 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $164,418 | $240,438 | $358,172 | $305,305 |
| Liabilities | – | – | – | – |
| Payables | $5,107 | $3,123 | $2,773 | $1,603 |
| Short-Term Debt | $24,864 | $3,308 | $2,872 | $2,316 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $62,293 | $63,048 | $60,263 | $69,799 |
| Total Curr. Liab. | $92,264 | $69,479 | $65,908 | $73,718 |
| LT Debt | $169,660 | $173,708 | $176,202 | $178,262 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $88,511 | $133,457 | $132,718 | $132,998 |
| Total NC Liab. | $258,171 | $307,165 | $308,920 | $311,260 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $7,150 | $6,097 | $8,969 | $11,285 |
| Total Liabilities | $350,435 | $376,644 | $374,828 | $384,978 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $13 | $12 | $12 | $8 |
| Retained Earnings | -$1,563,460 | -$1,487,038 | -$1,343,939 | -$1,178,648 |
| AOCI | -$356 | -$161 | -$638 | $191 |
| Other Equity | $1,377,786 | $1,350,981 | $1,327,909 | $1,098,776 |
| Total Equity | -$186,017 | -$136,206 | -$16,656 | -$79,673 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $164,418 | $240,438 | $358,172 | $305,305 |
| Net Debt | $132,048 | $124,785 | $43,886 | -$9,881 |